Contact

Copyright © 2019 EGI Capital 

  • Black LinkedIn Icon
  • Black Twitter Icon
  • Black Google+ Icon

1 Broadway, 14th Floor
Cambridge, MA 02142
USA

Email: info@egicapital.biz
Tel:  6174013068

your

SUCCESS

is our

business

 

Portfolio

OW.JPG
SIC.JPG
manusbio.JPG
Innova.JPG
neutrolis.JPG
PolyQolor.JPG
images.png
JJPLUS.JPG
artus.JPG
TWBIO.JPG

FUNDS

 

vision fund

PaRtner

 

 Team

General Partner

Dr. Charles Hsu

  • Grey LinkedIn Icon

Senior Partner

Dr. June Huang

  • Grey LinkedIn Icon

Technical Advisor

Dr. Shu Chiung

  • Grey LinkedIn Icon

Associate

Bolong Xiong

  • Grey LinkedIn Icon

Analyst

Andy Chen

  • Grey LinkedIn Icon

Analyst

Coco Tsai

  • Grey LinkedIn Icon

Analyst

Freya Ma

  • Grey LinkedIn Icon

Analyst

Kevin Yu

  • Grey LinkedIn Icon

Analyst

Jason Lin

  • Grey LinkedIn Icon

Analyst

Sunny Shen

  • Grey LinkedIn Icon

Analyst

David Chen

  • Grey LinkedIn Icon

Analyst

Queenie Wang

  • Grey LinkedIn Icon

Advisory Board

 
 
 

About EGI Capital

EGI Capital is a venture capital and private equity firm based in Cambridge, MA. EGI Capital provides seed capital out of the Chong De Angel Fund, an angel group subsidiary within EGI Capital, and also provides equity to later stage IT (robotics, AI, IoT, new materials, FinTech, etc.) and healthcare companies. EGI Capital is backed by five public pharmaceutical companies and ten public IT and healthcare companies from Taiwan and Mainland China. Chong De Angel Fund provides up to $2M seed stage investments in early-stage companies, while EGI Capital provides equity of $2M - $5M per company post-seed stage. EGI Capital is also actively looking for PE and M&A opportunities worldwide in the $1~5B range. EGI Capital seeks companies on a global level, though has a focus in Boston and North America East Coast-based companies. 

 
Ms. Tracy Teng

Vice President, CRI